US 10857161
Non-hormonal steroid modulators of NF-kB for treatment of disease
granted A61KA61K31/57A61K31/573
Quick answer
US patent 10857161 (Non-hormonal steroid modulators of NF-kB for treatment of disease) held by ReveraGen BioPharma, Inc. expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ReveraGen BioPharma, Inc.
- Grant date
- Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/57, A61K31/573, A61K31/575, A61P